Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
US Army
QuintilesIMS
Fuji
US Department of Justice

Generated: April 20, 2019

DrugPatentWatch Database Preview

Betrixaban - Generic Drug Details

« Back to Dashboard

What are the generic sources for betrixaban and what is the scope of betrixaban freedom to operate?

Betrixaban is the generic ingredient in one branded drug marketed by Portola Pharms Inc and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Betrixaban has one hundred and twenty-six patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for betrixaban
International Patents:126
US Patents:10
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 52
Clinical Trials: 9
Patent Applications: 117
Formulation / Manufacturing:see details
DailyMed Link:betrixaban at DailyMed
Pharmacology for betrixaban
Drug ClassFactor Xa Inhibitor
Mechanism of ActionFactor Xa Inhibitors
Synonyms for betrixaban
330942-05-7
4CA-0269
74RWP7W0J9
942B057
AB0027977
AB1008465
ABP000384
AC-30214
AKOS005146070
AN-3565
API0007103
BC638590
BCP01903
BCP9000395
BDBM50249298
Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy-
Betrixaban (USAN)
Betrixaban [USAN:INN]
betrixaban/
Bevyxxa
CHEBI:140421
CHEMBL512351
compound 11 [PMID: 19297154]
CS-2481
D08873
DB12364
EX-A358
FT-0663094
GTPL9602
HY-10268
KB-75507
KS-00000645
MolPort-009-682-948
N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide
N-(5-chloro-2-pyridyl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxy-benzamide
N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- methoxybenzamide
N-(5-chloropyridin-2-yl)-2-({[4-(N,N-dimethylcarbamimidoyl)phenyl]carbonyl}amino)-5-methoxybenzamide
N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide
N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide
N-(5-chloropyridin-2-yl)-2-[4-(N,N-dimethylcarbamimidoyl)benzamido]-5-methoxybenzamide
NCGC00371122-02
PRT 054021
PRT-054021
PRT054021
QCR-99
SB16951
SCHEMBL158591
UNII-74RWP7W0J9
VA11998
W9900
ZINC30691754

US Patents and Regulatory Information for betrixaban

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-002 Jun 23, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-002 Jun 23, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-002 Jun 23, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-001 Jun 23, 2017 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-001 Jun 23, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-001 Jun 23, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fuji
Chinese Patent Office
Covington
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.